CGS-12066, also known as CGS-12066A and CGS-12066B, is a predominant serotonin 5-HT1B receptor agonist which was under development for the treatment of anxiety disorders but was never marketed.
The compounds of every Wikipedia article carrying a Chembox or a Drugbox, refreshed daily, with the values their infoboxes give. The pages need JavaScript; the API does not.